Sareum (SAR) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free SAR Stock Alerts GBX 30.50 -3.00 (-8.96%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSareum (LON:SAR) Stock Passes Below 50-Day Moving Average of $23.95americanbankingnews.com - April 24 at 4:54 AMSareum (LON:SAR) Shares Pass Below Fifty Day Moving Average of $26.03americanbankingnews.com - April 16 at 4:28 AMIssue of RiverFort Subscription Shareslse.co.uk - April 11 at 1:19 AMSareum Holdings PLC SARmorningstar.com - April 4 at 8:48 PMSareum Holdings: A decisive period ahead for SDC-1801uk.investing.com - April 4 at 10:47 AMTop 10 War Movies Based on Real Life You Can Watch on Netflixmsn.com - April 1 at 10:23 PMSareum Holdings touts new patent allowance for autoimmune therapylse.co.uk - March 17 at 8:24 AMSareum shares slump on widened loss and funding talkslse.co.uk - March 12 at 1:52 PMSareum Holdings plc (LON:SAR): Are Analysts Optimistic?finance.yahoo.com - February 28 at 1:48 AMSareum Holdings PLC (RYH0.SG)au.finance.yahoo.com - February 19 at 12:30 PMSareum hails safety profile for SDC-1801 after phase 1 triallse.co.uk - February 15 at 9:22 AMLONDON MARKET MIDDAY: London stocks make largely soft start to 2024lse.co.uk - January 2 at 8:48 AMSareum surges as partner agrees licence for promising moleculeproactiveinvestors.com.au - January 2 at 8:48 AMSareum soars as partner agrees SRA737 licence with US biopharma firmlse.co.uk - January 2 at 8:48 AMEARNINGS AND TRADING: CleanTech raises GBP520,000 in open offerlse.co.uk - December 14 at 6:13 PMSareum shares just jumped 22%! Here’s whyfool.co.uk - November 23 at 7:12 PMEARNINGS AND TRADING: MetalNRG hails Gold Ridge findingslse.co.uk - November 9 at 11:54 AMThe 25 Best Sad Movies On Netflix That Will Give You All The Feelsmsn.com - November 5 at 5:27 PMSareum says patent notice in Japan boosts confidence in SDC-1801lse.co.uk - November 3 at 8:19 AMSareum Holdings Nears Patent for Autoimmune Disease Treatment in Japanmarketwatch.com - November 3 at 8:19 AMFTSE 100 Live: Jeremy Hunt warns on UK economy, Arm dips below IPO price, Next seals FatFace dealmsn.com - October 13 at 4:01 PMLONDON MARKET EARLY CALL: Higher call as high rate narrative settleslse.co.uk - October 9 at 9:24 AMSareum says earnings down but product development going welllse.co.uk - October 9 at 9:24 AMLONDON MARKET CLOSE: Stocks end higher, shaking off US nonfarms beatlse.co.uk - October 6 at 5:15 PMSareum doses first subjects in second stage of Phase 1a trial of SDC-1801msn.com - September 5 at 8:27 AMSareum begins dosing participants in phase 1a trial for SDC-1801lse.co.uk - September 4 at 9:00 AM25 Best Netflix Movies Based On True Storiesmsn.com - August 22 at 6:45 PMNetflix: The thriller written by Angelina Jolie that is all the rage on the platform in the USmsn.com - July 15 at 9:53 PMTRADING UPDATES: New patents for Sareum; Guanajuato hails assessmentlse.co.uk - June 26 at 5:02 PMA thorough analysis of the Anaplastic Large Cell Lymphoma Treatment market Size with projected 13.7% CAGR growth from 2023 to 2030marketwatch.com - June 22 at 6:28 PMFresh blow to City as WE Soda pulls $7.5bn London IPOft.com - June 16 at 9:32 AMSAR.L - Sareum Holdings plcfinance.yahoo.com - May 25 at 11:06 PMTRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effectlse.co.uk - May 18 at 1:57 PMWe're Not Very Worried About Sareum Holdings' (LON:SAR) Cash Burn Ratefinance.yahoo.com - April 27 at 7:46 AMNON RECEPTOR TYROSINE PROTEIN KINASE TYK2 Market Size by 2031marketwatch.com - April 17 at 9:03 AMNon Receptor Tyrosine Protein Kinase TYK2 Market Demand by 2030marketwatch.com - April 7 at 8:06 AMShould I get invested in this FTSE pharma share?uk.news.yahoo.com - March 30 at 2:15 PMNew Market Report on Anaplastic Large Cell Lymphoma Comes With A Thorough Analysis Of Industry Trends, Share, Size.marketwatch.com - March 2 at 3:00 PMFollowing a 32% decline over last year, recent gains may please Sareum Holdings plc (LON:SAR) institutional ownersfinance.yahoo.com - February 7 at 8:32 AMNON RECEPTOR TYROSINE PROTEIN KINASE TYK2 Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries Datamarketwatch.com - January 23 at 9:44 AMSareum Holdings (LON:SAR) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - October 25 at 11:53 AMSMALL CAP MOVERS: Property lender Lendinvest sinks 36% to a new low of 64p over risk of falling property prices; Cybersecurity firm Intercede surges 39% - msnNOWmsn.com - October 14 at 6:08 PMGlaxosmithkline News Headlines. GSK Share News. Financial News Articles for Gsk Plc Ord 31 1/4P updated throughout the day. - London South Eastlse.co.uk - October 13 at 10:05 PMSareum Plunges 19% Amid GSK Unit's Plan To Return Cancer Medication Rights To CRT Pioneer Fund - Marketscreener.commarketscreener.com - October 12 at 9:55 AMNigeria's Forcados crude loadings to restart by end of October - SPDC | Financial News - London South Eastlse.co.uk - October 12 at 9:55 AMSareum Holdings Says Sierra Oncology To Return Cancer Treatment License; Shares Fall - MarketWatchmarketwatch.com - October 12 at 9:55 AMSmall Cap Feast - Critical Metals, Nightcap, Sareum Holdings, Spectra Systems, Altona Rare Earths and more... - Proactive Investors Australiaproactiveinvestors.com.au - September 13 at 3:40 PMCORRECT: Sareum notes US FDA approval of Bristol-Myers's Sotyktu - Morningstarmorningstar.co.uk - September 13 at 5:40 AMSareum receives US US Food & Drug Administration approval for Sotyktu - Morningstarmorningstar.co.uk - September 12 at 9:13 AMSareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update - GlobeNewswireglobenewswire.com - July 28 at 9:06 AM Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Thousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" SAR Media Mentions By Week SAR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAR News Sentiment▼0.000.43▲Average Medical News Sentiment SAR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAR Articles This Week▼10▲SAR Articles Average Week Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Synairgen News Today ImmuPharma News Today BiVictriX Therapeutics News Today Ondine Biomedical News Today OptiBiotix Health News Today Destiny Pharma News Today Roquefort Therapeutics News Today Oxford BioDynamics News Today Oncimmune News Today ValiRx News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SAR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
